The Innovation Paradox: Why Complex Drug Research is Not Being Rewarded

August 5, 2020

The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law. This article first appeared in Life Sciences Preview.